Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. The company offers swine vaccines, ruminant vaccine, diagnostic reagents, and pet biological products. It also provides monoclonal antibody drug for HIV treatment, anti-allergy anti-IgE monoclonal antibody drug, and anti-herpes simplex virus monoclonal antibody drugs. In addition, the company offers foot-and-mouth disease vaccines for pigs, cattle, and sheep; and porcine circovirus type 2 subunit vaccines. Shanghai Shen Lian Biomedical Corporation was founded in 2001 and is headquartered in Shanghai, China.
Frequently asked questions
What sector does Shanghai Shen Lian Biomedical Corp (688098) operate in?
Shanghai Shen Lian Biomedical Corp belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Shanghai Shen Lian Biomedical Corp (688098) current stock price?
As of the latest data, Shanghai Shen Lian Biomedical Corp stock price is CN¥7.94, with a previous close of CN¥7.98. Shanghai Shen Lian Biomedical Corp lost -CN¥0.04 in the last trading session, representing a -0.5% loss.
What is Shanghai Shen Lian Biomedical Corp (688098) current market capitalization?
Shanghai Shen Lian Biomedical Corp market cap is approximately 3.26 billion.
What is Shanghai Shen Lian Biomedical Corp (688098) Earnings Per Share (EPS)?
The trailing EPS is -CN¥0.07.
Does Shanghai Shen Lian Biomedical Corp (688098) pay dividends?
No. Shanghai Shen Lian Biomedical Corp does not pay a dividend.
What is Shanghai Shen Lian Biomedical Corp (688098) beta (volatility) score?
Shanghai Shen Lian Biomedical Corp has a beta of 0.548, indicating lower volatility than the overall market.
